174 related articles for article (PubMed ID: 9053020)
1. [HIV protease inhibitors].
Rubio R; Romeu J; Viciana P; Redondo C
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():10-4. PubMed ID: 9053020
[No Abstract] [Full Text] [Related]
2. [HIV protease inhibitors. A new drug class in antiretroviral therapy].
Mauss S; Seidlitz B; Jablonowski H; Häussinger D
Dtsch Med Wochenschr; 1996 Nov; 121(44):1369-74. PubMed ID: 8964223
[No Abstract] [Full Text] [Related]
3. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
[No Abstract] [Full Text] [Related]
4. The choice of HIV protease inhibitor: indinavir is currently the best option.
Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
[TBL] [Abstract][Full Text] [Related]
5. Viramune cleared for use in combination with protease inhibitors.
AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046
[No Abstract] [Full Text] [Related]
6. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
Klaus BD; Grodesky MJ
Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
[No Abstract] [Full Text] [Related]
7. Development of HIV protease inhibitors: a survey.
Ren S; Lien EJ
Prog Drug Res; 1998; 51():1-31. PubMed ID: 9949858
[TBL] [Abstract][Full Text] [Related]
8. What they say about protease inhibitors.
Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy and clinical trials: what now?
Lange JM; Richman DD
Antivir Ther; 1996 Apr; 1(2):69-70. PubMed ID: 11321181
[No Abstract] [Full Text] [Related]
10. A patient's guide to protease inhibitors.
Elperin A; Sax P
AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
[TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia associated with the use of protease inhibitors.
Smith JH; Martin GJ; Decker CF
Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
[No Abstract] [Full Text] [Related]
12. [FPV plus SQV plus a mini-dose ritonavir. "Double boosting with compatible partners].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():92-3. PubMed ID: 15373070
[No Abstract] [Full Text] [Related]
13. Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.
Bonfanti P; Capetti A; Di Mattei P; Niero F; Rizzardini G
AIDS; 1998 Jun; 12(9):1111. PubMed ID: 9662213
[No Abstract] [Full Text] [Related]
14. Ritonavir and indinavir one year later.
TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
[No Abstract] [Full Text] [Related]
15. Influence of indinavir and ritonavir on warfarin anticoagulant activity.
Gatti G; Alessandrini A; Camera M; Di Biagio A; Bassetti M; Rizzo F
AIDS; 1998 May; 12(7):825-6. PubMed ID: 9619821
[No Abstract] [Full Text] [Related]
16. Data in from first head-to-head protease inhibitor.
AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
[No Abstract] [Full Text] [Related]
17. Risk factors for ritonavir intolerance and outcome after change to indinavir.
Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A
AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044
[No Abstract] [Full Text] [Related]
18. Using ritonavir with indinavir in cases of virologic failure.
TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
[No Abstract] [Full Text] [Related]
19. Double protease inhibitor regimens with amprenavir show promise.
AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
[No Abstract] [Full Text] [Related]
20. [Clinical application of HIV protease inhibitors].
Chiba N; Shintani M; Ueno T; Hayashi H
Tanpakushitsu Kakusan Koso; 1998 May; 43(6):744-51. PubMed ID: 9612068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
